Condition
Metagenomic Next Generation Sequencing
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Not Yet Recruiting2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07525739Phase 4Not Yet Recruiting
Assessing Changes in the Gut Microbiome of Non-Gastrointestinal Disordered Subjects Before and After Oral Prebiotic Supplementation Using the SIMBA Capsule
NCT07671014Not Yet Recruiting
Metagenomic Analysis of the Pharynx in High Risk Partners
NCT03884881Not ApplicableUnknown
Second-generation Sequencing Guides the Treatment of Severe Pneumonia
Showing all 3 trials